Fc (human) Control (rec.)
| Code | Size | Price |
|---|
| AG-35B-0007-C050 | 50 ug | £140.00 |
Quantity:
| AG-35B-0007-2050 | 2 x 50 ug | £220.00 |
Quantity:
| AG-35B-0007-C500 | 500 ug | £640.00 |
Quantity:
| AG-35B-0007-M001 | 1 mg | £1,090.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Hamster
Regulatory Status: RUO
Target Species: Human
Shipping:
Blue Ice
Storage:
-20°C
Documents
Further Information
Concentration:
1mg/ml after reconstitution.
EClass:
32160000
Endotoxin:
<0.1EU/µg purified protein (LAL test; Lonza).
Form (Short):
liquid
Formulation:
Lyophilized. Contains PBS.
Handling Advice:
After reconstitution, prepare aliquots and store at -20°C.Avoid freeze/thaw cycles.Centrifuge lyophilized vial before opening and reconstitution.PBS containing at least 0.1% BSA should be used for further dilutions.
Long Description:
Protein. Recombinant Fc portion of human IgG1 (aa 105-330). Lyophilized. Contains PBS. Negative control in experiments with recombinant proteins fused to human IgG1 Fc.
Molecular Weight:
~28kDa (SDS-PAGE)
Package Type:
Plastic Vial
Product Description:
Negative control in experiments with recombinant proteins fused to human IgG1 Fc.
Purity:
>95% (SDS-PAGE)
Sequence:
Recombinant Fc portion of human IgG1 (aa 105-330).
Source / Host:
CHO cells
TAGs:
Fc
Transportation:
Non-hazardous
UNSPSC Category:
Other Proteins
UNSPSC Number:
12352202
Use & Stability:
Stable for at least 6 months after receipt when stored at -20°C.
References
Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses: M.K. Tveitaras, et al.; Exp. Cell Res. 359, 257 (2017) | RANKL signaling sustains primary tumor growth in genetically engineered mouse models of lung adenocarcinoma: J. Faget, et al.; J. Thoracic Oncol. 13, 387 (2017)
Related Products
| Product Name | Product Code | Supplier | Mouse IgG1 Isotype Control (MOPC31C) | ANC-278-010 | Ancell | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human IgG1 Isotype Control | ANC-295-010 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human IgG1 Isotype Control (Biotin) | ANC-295-030 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human IgG1 Isotype Control (FITC) | ANC-295-040 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human IgG1 Isotype Control (R-PE) | ANC-295-050 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human IgG1 Isotype Control (preservative free) | ANC-295-810 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||